Decoy Therapeutics Inc. (DCOY) vs Sunshine Biopharma, Inc. (SBFM)

A side-by-side comparison of Decoy Therapeutics Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DCOY

Decoy Therapeutics Inc.

$824550

$1.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SBFM

Sunshine Biopharma, Inc.

$946332

$0.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DCOY vs SBFM

growth of $100 · dividends reinvested · last 10y

DCOY -100.0% (-76.3%/yr)SBFM -100.0% (-74.0%/yr)SBFM compounded faster over this window

DCOY SBFM

DCOY vs SBFM: by the numbers

•SBFM is the larger company ($946332 vs $824550 market cap).
•Both run net losses; DCOY's is the smaller (0.00% vs -16.50% net margin).

Metrics side by side

Valuation

Metric	DCOY	SBFM
P/S ratio	N/A	0.03
P/B ratio	0.19	0.03

Profitability

Metric	DCOY	SBFM
Gross margin	0.00%	29.80%
Operating margin	0.00%	-14.71%
Net margin	0.00%	-16.50%
ROE	-334.41%	-21.18%
ROIC	-343.55%	-18.56%

Growth (annualized)

Metric	DCOY	SBFM
Revenue CAGR (5Y)	N/A	203.18%
Total return CAGR (5Y)	-86.39%	N/A

Go deeper

Full DCOY analysis Full SBFM analysis Interactive comparison tool

Dig into the metrics

Decoy Therapeutics ROE Sunshine Biopharma ROE Decoy Therapeutics operating margin Sunshine Biopharma operating margin Decoy Therapeutics revenue growth Sunshine Biopharma revenue growth Decoy Therapeutics free cash flow Sunshine Biopharma free cash flow

Decoy Therapeutics & Sunshine Biopharma appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.